| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/12/2006 | CN1250545C Quinuclidine derivatives and medicine composition containing the derivatives |
| 04/12/2006 | CN1250544C Pyridoarylphenyl oxazolidinone antibacterials and related compositions and methods |
| 04/12/2006 | CN1250526C Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 04/12/2006 | CN1250295C Magnetism and drug combined type fragrant baldric for avoiding plague |
| 04/12/2006 | CN1250290C Novel medicament compositions, based on anticholinergic effective compounds and beta-mimetiques |
| 04/12/2006 | CN1250282C Stable protein compositions |
| 04/12/2006 | CN1250280C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 04/12/2006 | CN1250257C Granule for clearing away the lung-heat and removing poison |
| 04/12/2006 | CN1250237C Application of single ingredient atractylodes macrocephala Koidz for preparation of treating chronic pharyngitis and larygopharyngitis correlation disease |
| 04/11/2006 | US7026510 Inhibitors of the chemotactic activation induced by the fraction C5a of complement and from other chemotactic proteins (chemokines) that y activate a 7-transmembrane-domain receptor; psoriasis, rheumatoid arthritis, ulcerative colitis, acute respiratory distress syndrome, fibrosis; antiischemic agents |
| 04/11/2006 | US7026501 Inhibitors of α4 mediated cell adhesion |
| 04/11/2006 | US7026491 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7026349 Sulfonamides |
| 04/11/2006 | US7026348 Antiinflammatory agents; sepsis shock; rheumatic diseases |
| 04/11/2006 | US7026335 Melanocortin receptor ligands |
| 04/11/2006 | US7026331 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct |
| 04/11/2006 | US7026326 Substituted heterocyclic compounds and methods of use |
| 04/11/2006 | US7026324 Amide containing a pyridinone or pyrazinone compound as serine protease enzyme inhibitors |
| 04/11/2006 | US7026319 Use of vitamin combination for the treatment of pruritus and non-infective disorders involving itching and/or inflammation |
| 04/11/2006 | US7026309 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 04/11/2006 | US7025960 For therapy of diseases which can be treated or alleviated by a stimulation of the production of cytokines, particularly of IL-12 |
| 04/11/2006 | CA2411008C Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| 04/06/2006 | WO2006036031A1 Fused furan derivative and use thereof |
| 04/06/2006 | WO2006035954A1 Carbostyril compound |
| 04/06/2006 | WO2006035936A1 Par-2 antagonists |
| 04/06/2006 | WO2006035759A1 Drug for treating respiratory disease |
| 04/06/2006 | WO2006035308A1 Histamine-3 receptor antagonists |
| 04/06/2006 | WO2006035303A1 Muscarinic receptor antagonists |
| 04/06/2006 | WO2006035280A1 3,4-dihydroisoquinoline compounds as muscrinic receptor antagonists for the treatment of respiratory, urinary and gastrointestinal diseases |
| 04/06/2006 | WO2005100373A3 Monosaccharide derivatives as anti-cancer and anti-inflammatory agents |
| 04/06/2006 | WO2005041931A3 Pharmaceutical aerosol compositions |
| 04/06/2006 | US20060074244 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 04/06/2006 | US20060074233 Detect binding with cells transfected with DNA |
| 04/06/2006 | US20060074123 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/06/2006 | US20060074110 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/06/2006 | US20060074106 Treatment of inflammatory disorders |
| 04/06/2006 | US20060074092 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin K inhibitory activity for the treatment of inflammations and other diseases |
| 04/06/2006 | US20060074069 e.g. (2R-trans) [4-(4-azetidin-3-yl-piperazin-1-yl)-2-benzyl-piperidin-1-yl]-(3,5-bis-trifluoromethyl-phenyl)-methanone;tachykinins, substance P inhibitor; antidepressant, anxiolytic, antiinflammatory agent, cognition activator; neurodegenerative diseases; addiction, sleep, eating disorders |
| 04/06/2006 | US20060074068 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
| 04/06/2006 | US20060074062 Substituted porphyrins |
| 04/06/2006 | US20060073567 Novel insulin/IGF/relaxin family polypeptides and DNAs thereof |
| 04/06/2006 | US20060073516 Novel screening method |
| 04/06/2006 | US20060073472 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| 04/06/2006 | US20060073215 Cough depressant composition containing iron for angiotensin-converting enzyme inhibitor inducing cough |
| 04/06/2006 | US20060073166 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR |
| 04/06/2006 | US20060073156 Fosfomycin and n-acetylcysteine for the treatment of biofilms caused by escheric ia coli and other pathogens of the urinary tract |
| 04/06/2006 | DE10231370B4 Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel Thiophenglycosidderivate, pharmaceutical compositions containing them and methods for making these drugs |
| 04/06/2006 | DE102004050591A1 Schleimdrogenbasierte Lutschtablette gegen entzündliche Erkrankungen des Mund- und Rachenraums Mucus drugs based lozenge against inflammatory diseases of the mouth and throat |
| 04/06/2006 | DE102004050589A1 Topical composition (in solid dosage form), useful to treat inflammatory diseases of mouth and throat e.g. tonsillitis, laryngitis, pharyngitis and gingivitis, comprises combination of Lichen islandicus and a local anesthetic |
| 04/06/2006 | DE102004045220A1 Neue Arzneimittel New drugs |
| 04/06/2006 | CA2581741A1 Histamine-3 receptor antagonists |
| 04/06/2006 | CA2581575A1 Medicinal aerosol formulations and methods of synthesizing ingredients therefor |
| 04/06/2006 | CA2580811A1 Carbostyril compound |
| 04/05/2006 | EP1642973A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642972A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642596A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/05/2006 | EP1642591A1 MEDICINAL COMPOSITION CONTAINING NF-kAPPA B DECOY FOR TREATING AND PREVENTING RESPIRATORY DISEASES AND METHOD OF USING THE SAME |
| 04/05/2006 | EP1642589A1 Preventives/remedies for snore or respiratory disturbances during sleep |
| 04/05/2006 | EP1642574A2 Combination of a beta-2 adrenoceptor agonist and an aminosugar and their use for the treatment of immunomodulatory disorders |
| 04/05/2006 | EP1641779A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator. |
| 04/05/2006 | EP1641744A2 Crystalline form of b2 adrenergic receptor agonist |
| 04/05/2006 | EP1641741A1 Levalbuterol hydrochloride polymorph b |
| 04/05/2006 | EP1641518A1 Method and device for treating osteoarthritis, cartilage disease, defects and injuries in the human knee |
| 04/05/2006 | EP1641485A1 Inhibition of sars coronavirus infection with clinically approved antiviral drugs |
| 04/05/2006 | EP1641469A1 Aivlosin for the treatment of disease due to brachyspira pilosicoli or ornithobacterium rhinotracheale |
| 04/05/2006 | EP1641446A1 Pharmaceutical compositions including an antihistamine and a stimulant and use thereof |
| 04/05/2006 | EP1641442A1 Use of osmolytes obtained from extremophilic bacteria for the production of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases and an inhalation device comprising an osmolyte as active agent component |
| 04/05/2006 | EP1453777B1 Functionalized higher diamondoids |
| 04/05/2006 | EP1438104B1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 04/05/2006 | EP1383522B1 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of inflammatory skin conditions |
| 04/05/2006 | EP1320361A4 Method for reducing exacerbations associated with copd |
| 04/05/2006 | EP1320355B1 System for delivering a tobramycin formulation |
| 04/05/2006 | EP1305319B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/05/2006 | EP1147413B1 Growth differentiation factor inhibitors and uses therefor |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | CN1756546A Microglia inhibitors for interrupting interleukin 12 and ifn-gamma-mediated immune reactions |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1754573A Use of immunoglobulin and cell growth factor in preparing medicine for asthma |
| 04/05/2006 | CN1754557A Chinese caterpillar fungus formulation preparation method |
| 04/05/2006 | CN1754552A Use of alpine yarrow herb effective parts in preparing medicine for respiratory tract virus |
| 04/05/2006 | CN1754549A Chinese caterpillar fungus formulation preparation method |
| 04/05/2006 | CN1754548A Chinese caterpillar fungus injection preparation method |
| 04/05/2006 | CN1754542A Compound pharmaceutical composition for treating wind-warm lung-heat disease and its preparation method |
| 04/05/2006 | CN1249233C Surface proteins of chlamydia pneumoniae |
| 04/05/2006 | CN1249087C Novel human G-Protein coupled receptor |
| 04/05/2006 | CN1249084C Human SARS virus surface membrane protein antigen determinant polypeptide, polynucleotide sequence and its use |
| 04/05/2006 | CN1249083C Polypeptide drug for inhibiting SARS coronavirus from infecting host cell |
| 04/05/2006 | CN1249074C 2-aminocarbonyl-9H-punine derivatives |
| 04/05/2006 | CN1249067C Extracting process for bilobalide A, B, C and its preparation |
| 04/05/2006 | CN1249066C 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/05/2006 | CN1249063C Immunoregulatory compounds |
| 04/05/2006 | CN1249059C Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/05/2006 | CN1249033C Cyclic amp-specific phosphodiesterase inhibitors |
| 04/05/2006 | CN1249026C N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 04/05/2006 | CN1249025C Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha |
| 04/05/2006 | CN1248725C Compound traditional Chinese medicine preparation for acute , chronic pharyngitis and tonsillitis |
| 04/05/2006 | CN1248718C Medicinal composition for treating mycoplasma pneumonia and preparation method and quality-control method |
| 04/05/2006 | CN1248705C Cough and asthma emplastrum |
| 04/05/2006 | CN1248682C Drug for treating asthma |